Detalles de la búsqueda
1.
Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
Cancer Immunol Immunother
; 72(8): 2769-2782, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37166484
2.
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.
Am J Hematol
; 97(4): 458-469, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35064928
3.
Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing.
Ann Hematol
; 99(11): 2611-2617, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32980888
4.
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Ann Hematol
; 99(8): 1883-1893, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32572523
5.
Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.
Ann Hematol
; 98(1): 185-193, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143831
6.
Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia.
Ann Hematol
; 98(5): 1267-1277, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30747249
7.
Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
Ann Hematol
; 98(9): 2163-2177, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31243569
8.
Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies.
Br J Haematol
; 176(1): 92-100, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27714774
9.
Who is the best donor for a related HLA haplotype-mismatched transplant?
Blood
; 124(6): 843-50, 2014 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24916508
10.
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.
Int J Cancer
; 136(7): 1697-707, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25138425
11.
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.
Blood
; 121(20): 4056-62, 2013 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23535063
12.
Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.
Ann Hematol
; 94(1): 117-28, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25069650
13.
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Clin Transplant
; 29(7): 594-605, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25969866
14.
Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(7): 929-36, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24631740
15.
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes.
Biol Blood Marrow Transplant
; 20(12): 2023-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25196855
16.
Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission.
Biol Blood Marrow Transplant
; 20(9): 1314-21, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24747334
17.
Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
Blood
; 119(14): 3256-62, 2012 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22337715
18.
The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission.
Blood
; 119(23): 5584-90, 2012 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22535659
19.
Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation.
Am J Hematol
; 89(1): 55-61, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24009106
20.
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center study.
Am J Hematol
; 89(2): 130-6, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24122923